CMC1
gene geneOn this page
Also known as MGC61571
Summary
CMC1 (C-X9-C motif containing 1, HGNC:28783) is a protein-coding gene on chromosome 3p24.1, encoding COX assembly mitochondrial protein homolog (Q7Z7K0). Component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly.
Predicted to enable metal ion binding activity. Located in mitochondrion.
Source: NCBI Gene 152100 — RefSeq curated summary.
At a glance
- GWAS associations: 14
- Clinical variants (ClinVar): 29 total
- MANE Select transcript:
NM_182523
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28783 |
| Approved symbol | CMC1 |
| Name | C-X9-C motif containing 1 |
| Location | 3p24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC61571 |
| Ensembl gene | ENSG00000187118 |
| Ensembl biotype | protein_coding |
| OMIM | 615166 |
| Entrez | 152100 |
Gene structure
Transcript identifiers
Ensembl transcripts: 20 — 11 protein_coding, 6 protein_coding_CDS_not_defined, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000334841, ENST00000396610, ENST00000418849, ENST00000423894, ENST00000466830, ENST00000467644, ENST00000468330, ENST00000469102, ENST00000477739, ENST00000482499, ENST00000495428, ENST00000897767, ENST00000897768, ENST00000897769, ENST00000897770, ENST00000897771, ENST00000922195, ENST00000922196, ENST00000922197, ENST00000971159
RefSeq mRNA: 7 — MANE Select: NM_182523
NM_001331185, NM_001331186, NM_001331187, NM_001331189, NM_001331190, NM_001412155, NM_182523
CCDS: CCDS33722, CCDS87055
Canonical transcript exons
ENST00000466830 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001525639 | 28241619 | 28241812 |
| ENSE00001870901 | 28319509 | 28325142 |
| ENSE00003470605 | 28316333 | 28316423 |
| ENSE00003486079 | 28263291 | 28263380 |
Expression profiles
Bgee: expression breadth ubiquitous, 252 present calls, max score 98.09.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 32.4066 / max 464.8089, expressed in 1818 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 35780 | 30.8605 | 1818 |
| 35785 | 1.3702 | 79 |
| 35783 | 0.1130 | 33 |
| 35784 | 0.0629 | 24 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 98.09 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 95.39 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 94.86 | gold quality |
| spleen | UBERON:0002106 | 94.54 | gold quality |
| right atrium auricular region | UBERON:0006631 | 93.87 | gold quality |
| heart left ventricle | UBERON:0002084 | 93.86 | gold quality |
| cardiac ventricle | UBERON:0002082 | 93.74 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.69 | gold quality |
| heart right ventricle | UBERON:0002080 | 93.65 | gold quality |
| cardiac atrium | UBERON:0002081 | 93.64 | gold quality |
| myocardium | UBERON:0002349 | 93.21 | silver quality |
| heart | UBERON:0000948 | 93.17 | gold quality |
| vastus lateralis | UBERON:0001379 | 92.74 | silver quality |
| right lobe of liver | UBERON:0001114 | 92.54 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 92.43 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 92.25 | gold quality |
| quadriceps femoris | UBERON:0001377 | 92.02 | silver quality |
| right adrenal gland cortex | UBERON:0035827 | 91.88 | gold quality |
| right adrenal gland | UBERON:0001233 | 91.72 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 91.57 | gold quality |
| transverse colon | UBERON:0001157 | 91.16 | gold quality |
| left adrenal gland | UBERON:0001234 | 91.07 | gold quality |
| colonic mucosa | UBERON:0000317 | 91.05 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 90.95 | silver quality |
| palpebral conjunctiva | UBERON:0001812 | 90.90 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 90.88 | gold quality |
| leukocyte | CL:0000738 | 90.79 | gold quality |
| adenohypophysis | UBERON:0002196 | 90.78 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 90.75 | gold quality |
| gastrocnemius | UBERON:0001388 | 90.74 | gold quality |
Single-cell (SCXA)
Detected in 20 experiment(s), a significant marker in 20.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-10553 | yes | 6728.74 |
| E-HCAD-9 | yes | 3439.39 |
| E-CURD-46 | yes | 2895.00 |
| E-HCAD-1 | yes | 2695.28 |
| E-MTAB-7407 | yes | 2648.06 |
| E-HCAD-10 | yes | 2141.80 |
| E-MTAB-8207 | yes | 1919.97 |
| E-CURD-122 | yes | 1293.57 |
| E-CURD-85 | yes | 1250.40 |
| E-MTAB-8911 | yes | 885.62 |
| E-HCAD-4 | yes | 190.40 |
| E-MTAB-6701 | yes | 148.31 |
| E-MTAB-9467 | yes | 66.45 |
| E-MTAB-10287 | yes | 30.99 |
| E-CURD-88 | yes | 29.60 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
21 targeting CMC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-8080 | 99.82 | 67.52 | 1342 |
| HSA-MIR-548AG | 99.77 | 69.25 | 1492 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-548AI | 99.69 | 69.24 | 1494 |
| HSA-MIR-548BA | 99.69 | 69.14 | 1514 |
| HSA-MIR-570-5P | 99.69 | 69.24 | 1494 |
| HSA-MIR-587 | 99.64 | 70.86 | 2611 |
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-3140-5P | 99.39 | 69.04 | 1136 |
| HSA-MIR-6505-3P | 99.34 | 67.39 | 1071 |
| HSA-MIR-4477B | 99.23 | 70.49 | 1733 |
| HSA-MIR-5100 | 99.11 | 67.52 | 1098 |
| HSA-MIR-513B-3P | 98.76 | 68.12 | 1577 |
| HSA-MIR-5581-3P | 98.55 | 70.31 | 1161 |
| HSA-MIR-4759 | 97.39 | 65.86 | 608 |
| HSA-MIR-617 | 96.79 | 65.96 | 738 |
| HSA-MIR-6816-3P | 95.05 | 66.08 | 459 |
Literature-anchored findings (GeneRIF, showing 1)
- our data indicate that CMC1 regulates turnover of newly synthesized COX1 prior to and during COX1 maturation, without affecting the rate of COX1 synthesis. (PMID:28082314)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cmc1 | ENSMUSG00000039163 |
| rattus_norvegicus | Cmc1 | ENSRNOG00000010149 |
Protein
Protein identifiers
COX assembly mitochondrial protein homolog — Q7Z7K0 (reviewed: Q7Z7K0)
All UniProt accessions (3): C9JES7, F8WAC1, Q7Z7K0
UniProt curated annotations — full annotation on UniProt →
Function. Component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly.
Subunit / interactions. Component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, the core components of this complex being COA3/MITRAC12 and COX14.
Subcellular location. Mitochondrion.
Similarity. Belongs to the CMC family.
RefSeq proteins (7): NP_001318114, NP_001318115, NP_001318116, NP_001318118, NP_001318119, NP_001399084, NP_872329* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013892 | Cyt_c_biogenesis_Cmc1-like | Family |
Pfam: PF08583
UniProt features (9 total): short sequence motif 2, disulfide bond 2, initiator methionine 1, chain 1, domain 1, modified residue 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z7K0-F1 | 87.18 | 0.77 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 2
Disulfide bonds (2): 31–63, 41–53
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9864848 | Complex IV assembly |
MSigDB gene sets: 92 (showing top):
GOBP_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY, GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY, GOBP_CYTOCHROME_COMPLEX_ASSEMBLY, WEI_MYCN_TARGETS_WITH_E_BOX, GOBP_PROTEIN_MATURATION, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_PROTEIN_FOLDING, MILI_PSEUDOPODIA_CHEMOTAXIS_UP, ACEVEDO_LIVER_CANCER_UP, NUYTTEN_EZH2_TARGETS_DN, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN, GOCC_MITOCHONDRIAL_MATRIX, GOCC_ORGANELLE_ENVELOPE_LUMEN, GOCC_ORGANELLE_ENVELOPE, BRUINS_UVC_RESPONSE_LATE
GO Biological Process (0):
GO Molecular Function (1): metal ion binding (GO:0046872)
GO Cellular Component (2): mitochondrion (GO:0005739), mitochondrial matrix (GO:0005759)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Respiratory electron transport | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cation binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| mitochondrion | 1 |
| intracellular organelle lumen | 1 |
Protein interactions and networks
STRING
536 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CMC1 | COX14 | Q96I36 | 656 |
| CMC1 | COA3 | Q9Y2R0 | 618 |
| CMC1 | AZI2 | Q9H6S1 | 499 |
| CMC1 | PET117 | Q6UWS5 | 488 |
| CMC1 | COX16 | Q9P0S2 | 485 |
| CMC1 | ZFC3H1 | O60293 | 480 |
| CMC1 | TMC5 | Q6UXY8 | 455 |
| CMC1 | COA6 | Q5JTJ3 | 443 |
| CMC1 | COA5 | Q86WW8 | 400 |
| CMC1 | CMC2 | Q9NRP2 | 395 |
| CMC1 | COX11 | Q9Y6N1 | 390 |
| CMC1 | CMC4 | P56277 | 380 |
| CMC1 | SCO1 | O75880 | 378 |
| CMC1 | COA1 | Q9GZY4 | 370 |
| CMC1 | CHCHD7 | Q9BUK0 | 366 |
| CMC1 | PET100 | P0DJ07 | 366 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| COA3 | MT-CO1 | psi-mi:“MI:0915”(physical association) | 0.610 |
| CMC1 | H2BC14 | psi-mi:“MI:0915”(physical association) | 0.400 |
| MAPT | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| CCL3L1 | QSOX1 | psi-mi:“MI:0914”(association) | 0.350 |
| EDDM3A | PLXNA2 | psi-mi:“MI:0914”(association) | 0.350 |
| COA3 | COX5B | psi-mi:“MI:0914”(association) | 0.350 |
| COA3 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| CMC1 | MT-CO1 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC25A5 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| PARL | HAX1 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (14): CMC1 (Affinity Capture-RNA), HIST1H2BM (Proximity Label-MS), CMC1 (Proximity Label-MS), CMC1 (Affinity Capture-MS), CMC1 (Affinity Capture-MS), CMC1 (Affinity Capture-MS), CMC1 (Affinity Capture-MS), CMC1 (Affinity Capture-MS), CMC1 (Affinity Capture-MS), CMC1 (Proximity Label-MS), CMC1 (Affinity Capture-MS), CMC1 (Proximity Label-MS), CMC1 (Proximity Label-MS), CMC1 (Affinity Capture-MS)
ESM2 similar proteins: A8E4L1, D2K759, F1QH17, O46404, O70133, P0DI19, P35614, P35615, P62495, P62496, P62497, P62498, P83870, P83871, Q0VCX5, Q0WMV8, Q0WWE3, Q15691, Q3ZBD9, Q49B96, Q5R4C7, Q5R7Z5, Q5U2Q7, Q5XIT1, Q5ZKU1, Q5ZLC7, Q61166, Q61187, Q64143, Q66HR2, Q66T82, Q68FK8, Q6IRE4, Q6PER3, Q6V291, Q76EZ2, Q7RTV0, Q7Z7K0, Q7ZYA7, Q8BWY3
Diamond homologs: Q3SZM6, Q7Z7K0, Q9CPZ8
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| CMC1 | “form complex” | “MITRAC complex” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
29 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 20 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1758 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:28294527:GTA:G | donor_gain | 1.0000 |
| 3:28316419:GCTTA:G | donor_gain | 1.0000 |
| 3:28316420:CTTA:C | donor_gain | 1.0000 |
| 3:28316421:TTA:T | donor_gain | 1.0000 |
| 3:28316422:TA:T | donor_gain | 1.0000 |
| 3:28316423:AG:A | donor_loss | 1.0000 |
| 3:28316424:G:C | donor_loss | 1.0000 |
| 3:28316424:G:GG | donor_gain | 1.0000 |
| 3:28316425:TAA:T | donor_loss | 1.0000 |
| 3:28316426:AA:A | donor_loss | 1.0000 |
| 3:28319622:GCAT:G | donor_gain | 1.0000 |
| 3:28319626:G:GG | donor_gain | 1.0000 |
| 3:28319653:G:GT | donor_gain | 1.0000 |
| 3:28319654:A:T | donor_gain | 1.0000 |
| 3:28319670:G:GT | donor_gain | 1.0000 |
| 3:28319670:G:T | donor_gain | 1.0000 |
| 3:28324451:CAGG:C | acceptor_gain | 1.0000 |
| 3:28324455:C:CC | acceptor_gain | 1.0000 |
| 3:28241808:CGCAG:C | donor_loss | 0.9900 |
| 3:28241809:GCAGG:G | donor_loss | 0.9900 |
| 3:28241810:CAGG:C | donor_loss | 0.9900 |
| 3:28241811:AGGT:A | donor_loss | 0.9900 |
| 3:28241812:GGTAC:G | donor_loss | 0.9900 |
| 3:28241813:G:GA | donor_loss | 0.9900 |
| 3:28241814:T:G | donor_loss | 0.9900 |
| 3:28263289:A:AG | acceptor_gain | 0.9900 |
| 3:28263290:G:GG | acceptor_gain | 0.9900 |
| 3:28263290:GACCA:G | acceptor_gain | 0.9900 |
| 3:28294525:TAGTA:T | donor_gain | 0.9900 |
| 3:28294529:AGTG:A | donor_gain | 0.9900 |
AlphaMissense
707 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:28263350:G:C | A27P | 0.994 |
| 3:28316380:T:A | C53S | 0.994 |
| 3:28316380:T:C | C53R | 0.994 |
| 3:28316381:G:C | C53S | 0.994 |
| 3:28263362:T:A | C31S | 0.992 |
| 3:28263363:G:C | C31S | 0.992 |
| 3:28316336:T:C | F38S | 0.992 |
| 3:28263351:C:A | A27D | 0.991 |
| 3:28263362:T:C | C31R | 0.991 |
| 3:28316335:T:C | F38L | 0.991 |
| 3:28316337:T:A | F38L | 0.991 |
| 3:28316337:T:G | F38L | 0.991 |
| 3:28316414:T:C | L64P | 0.991 |
| 3:28263327:T:A | I19N | 0.990 |
| 3:28263313:A:C | E14D | 0.989 |
| 3:28263313:A:T | E14D | 0.989 |
| 3:28263364:T:G | C31W | 0.989 |
| 3:28316336:T:G | F38C | 0.989 |
| 3:28263327:T:G | I19S | 0.987 |
| 3:28263363:G:A | C31Y | 0.987 |
| 3:28316344:T:C | C41R | 0.987 |
| 3:28263309:T:A | V13D | 0.986 |
| 3:28263312:A:T | E14V | 0.985 |
| 3:28263321:T:A | V17D | 0.985 |
| 3:28263343:A:C | R24S | 0.985 |
| 3:28263343:A:T | R24S | 0.985 |
| 3:28316344:T:A | C41S | 0.985 |
| 3:28316345:G:C | C41S | 0.985 |
| 3:28319549:T:G | Y81D | 0.984 |
| 3:28319570:T:C | F88L | 0.984 |
dbSNP variants (sampled 300 via entrez): RS1000025137 (3:28240768 G>C), RS1000036405 (3:28241079 A>T), RS1000052229 (3:28242232 T>C,G), RS1000056636 (3:28305325 T>C), RS1000056974 (3:28260602 A>G), RS1000076939 (3:28262359 C>T), RS1000087449 (3:28304964 A>G), RS1000128842 (3:28272862 T>G), RS1000138204 (3:28283268 C>T), RS1000159358 (3:28280624 G>T), RS1000168826 (3:28264078 A>G,T), RS1000270345 (3:28245101 A>G), RS1000311757 (3:28287419 C>T), RS1000338961 (3:28313870 A>T), RS1000371374 (3:28314174 C>T)
Disease associations
OMIM: gene MIM:615166 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
14 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003622_23 | Systemic lupus erythematosus | 5.000000e-06 |
| GCST004627_94 | Lymphocyte count | 2.000000e-14 |
| GCST004632_140 | Lymphocyte percentage of white cells | 4.000000e-12 |
| GCST005537_12 | Chronic inflammatory diseases (ankylosing spondylitis, Crohn’s disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) | 4.000000e-07 |
| GCST005859_2 | Liver transplant-free survival in primary sclerosing cholangitis (time to event) | 9.000000e-07 |
| GCST005997_9 | Lymphocyte count | 2.000000e-08 |
| GCST007124_3 | Multiple sclerosis and HDL levels (pleiotropy) | 3.000000e-07 |
| GCST010002_418 | Refractive error | 1.000000e-08 |
| GCST011096_21 | Systemic lupus erythematosus | 1.000000e-08 |
| GCST011956_74 | Systemic lupus erythematosus | 8.000000e-09 |
| GCST90002388_189 | Lymphocyte count | 1.000000e-20 |
| GCST90002389_13 | Lymphocyte percentage of white cells | 2.000000e-28 |
| GCST90002394_230 | Monocyte percentage of white cells | 1.000000e-09 |
| GCST90011866_12 | Systemic lupus erythematosus | 6.000000e-08 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004587 | lymphocyte count |
| EFO:0007993 | lymphocyte percentage of leukocytes |
| EFO:0004612 | high density lipoprotein cholesterol measurement |
| EFO:0007989 | monocyte percentage of leukocytes |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression | 2 |
| sodium arsenite | affects expression, increases abundance, increases expression | 2 |
| urushiol | increases expression | 1 |
| arsenite | increases reaction, affects binding | 1 |
| ICG 001 | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Rotenone | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
| Volatile Organic Compounds | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.